PL450540A1 - Funkcjonalizowane esterquaty L-karnityny i kwasu 2-furanokarboksylowego, sposób ich otrzymania oraz zastosowanie jako substancje antyseptyczne - Google Patents

Funkcjonalizowane esterquaty L-karnityny i kwasu 2-furanokarboksylowego, sposób ich otrzymania oraz zastosowanie jako substancje antyseptyczne

Info

Publication number
PL450540A1
PL450540A1 PL450540A PL45054024A PL450540A1 PL 450540 A1 PL450540 A1 PL 450540A1 PL 450540 A PL450540 A PL 450540A PL 45054024 A PL45054024 A PL 45054024A PL 450540 A1 PL450540 A1 PL 450540A1
Authority
PL
Poland
Prior art keywords
esterquats
carnitine
functionalized
preparation
furoic acid
Prior art date
Application number
PL450540A
Other languages
English (en)
Inventor
Michał NIEMCZAK
Adriana Olejniczak
Witold Stachowiak
Original Assignee
Politechnika Poznańska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Poznańska filed Critical Politechnika Poznańska
Priority to PL450540A priority Critical patent/PL450540A1/pl
Publication of PL450540A1 publication Critical patent/PL450540A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/62—Quaternary ammonium compounds
    • C07C211/63—Quaternary ammonium compounds having quaternised nitrogen atoms bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Przedmiotem zgłoszenia są funkcjonalizowane esterquaty L-karnityny i kwasu 2-furanokarboksylowego o wzorze ogólnym 1, gdzie R oznacza nierozgałęziony podstawnik alkilowy z wiązaniami nasyconymi zawierający 4, 8 lub 12 atomów węgla, sposób ich otrzymania oraz zastosowanie jako substancje antyseptyczne.
PL450540A 2024-12-11 2024-12-11 Funkcjonalizowane esterquaty L-karnityny i kwasu 2-furanokarboksylowego, sposób ich otrzymania oraz zastosowanie jako substancje antyseptyczne PL450540A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL450540A PL450540A1 (pl) 2024-12-11 2024-12-11 Funkcjonalizowane esterquaty L-karnityny i kwasu 2-furanokarboksylowego, sposób ich otrzymania oraz zastosowanie jako substancje antyseptyczne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL450540A PL450540A1 (pl) 2024-12-11 2024-12-11 Funkcjonalizowane esterquaty L-karnityny i kwasu 2-furanokarboksylowego, sposób ich otrzymania oraz zastosowanie jako substancje antyseptyczne

Publications (1)

Publication Number Publication Date
PL450540A1 true PL450540A1 (pl) 2026-06-15

Family

ID=100212546

Family Applications (1)

Application Number Title Priority Date Filing Date
PL450540A PL450540A1 (pl) 2024-12-11 2024-12-11 Funkcjonalizowane esterquaty L-karnityny i kwasu 2-furanokarboksylowego, sposób ich otrzymania oraz zastosowanie jako substancje antyseptyczne

Country Status (1)

Country Link
PL (1) PL450540A1 (pl)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160000066A1 (en) * 2013-02-28 2016-01-07 Institut National De La Recherche Agronomique (Inra) Furfural derivatives as a vehicle
WO2018068825A1 (en) * 2016-10-11 2018-04-19 Symrise Ag Antimicrobial compositions
WO2023250486A1 (en) * 2022-06-24 2023-12-28 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Fatty acid compounds
PL444849A1 (pl) * 2023-05-10 2024-03-25 Politechnika Poznanska Nowe czwartorzędowe sole amoniowe z kationem pochodzącym od lidokainy i anionem 2-pirośluzanowym, sposób ich otrzymywania oraz zastosowanie jako środki bakteriostatyczne i bakteriobójcze

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160000066A1 (en) * 2013-02-28 2016-01-07 Institut National De La Recherche Agronomique (Inra) Furfural derivatives as a vehicle
WO2018068825A1 (en) * 2016-10-11 2018-04-19 Symrise Ag Antimicrobial compositions
WO2023250486A1 (en) * 2022-06-24 2023-12-28 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Fatty acid compounds
PL444849A1 (pl) * 2023-05-10 2024-03-25 Politechnika Poznanska Nowe czwartorzędowe sole amoniowe z kationem pochodzącym od lidokainy i anionem 2-pirośluzanowym, sposób ich otrzymywania oraz zastosowanie jako środki bakteriostatyczne i bakteriobójcze

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOANNA FEDOROWICZ ET AL.,: "Int. J. Mol. Sci. 2024, 25(9), 4649, 24.04.2024 https://www.mdpi.com/1422-0067/25/9/4649", ADVANCES IN THE SYNTHESIS OF BIOLOGICALLY ACTIVE QUATERNARY AMMONIUM COMPOUNDS *